Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4

Molecular Biology of the Cell

Volumn 15, Issue 11, 2004, Pages 5012-5020

  Degnin, Catherine ^a   Jean, François ^b,c   Thomas, Gary ^b   Christian, Jan L ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; PROTEASOME; PROTEIN PRECURSOR; PROTEOHEPARAN SULFATE;

ACIDITY; ANIMAL CELL; ARTICLE; BINDING SITE; CELL COMPARTMENTALIZATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; DNA, COMPLEMENTARY; FURIN; HEPARAN SULFATE PROTEOGLYCANS; HISTIDINE; HYDROGEN-ION CONCENTRATION; IMMUNOPRECIPITATION; KINETICS; LIGANDS; LYSOSOMES; MODELS, BIOLOGICAL; OOCYTES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEOME; SIGNAL TRANSDUCTION; XENOPUS;

ANIMALIA;

EID: 6344272882     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-08-0673     Document Type: Article

References (61)

1. Andersen, E.D., Molloy, S.S., Jean, F., Fei, H., Shimamura, S., and Thomas, G. (2002). The ordered and compartment-specfific autoproteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J. Biol. Chem. 277, 12879-12890.
2. Anderson, E.D., Thomas, L., Hayflick, J.S., and Thomas, G. (1993). Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J. Biol. Chem. 268, 24887-24891.
3. Anderson, E.D., VanSlyke, J.K., Thulin, C.D., Jean, F., and Thomas, G. (1997). Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 16, 1508-1518.
4. Aono, A., Hazama, M., Notoya, K., Taketomi, S., Yamasaki, H., Tsukuda, R., Sasaki, S., and Fujisawa, Y. (1995). Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem. Biophys. Res. Commun. 210, 670-677.
5. Babst, M. (2004). GGAing ubiquitin to the endosome. Nat. Cell Biol. 6, 175-177.
6. Bergeron, E., Basak, A., Decroly, E., and Seidah, N.G. (2003). Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem. J. 373, 475-484.
7. Bonifacino, J.S., and Traub, L.M. (2003). Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72, 395-447.
8. Brunet, L.J., McMahon, J.A., McMahon, A.P., and Harland, R.M. (1998). Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-1457.
9. Chang, B., et al. (2001). Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2, 18.
10. Constam, D.B., and Robertson, E.J. (1999). Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 144, 139-149.
11. Cui, Y., Hackenmiller, R., Berg, L., Jean, F., Nakayama, T., Thomas, G., and Christian, J.L. (2001). The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev. 15, 2797-2802.
12. Cui, Y., Jean, F., Thomas, G., and Christian, J.L. (1998). BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development [In Process Citation]. EMBO J. 17, 4735-4743.
13. Dunn, N.R., Winnier, G.E., Hargett, L.K., Schrick, J.J., Fogo, A.B., and Hogan, B.L. (1997). Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. 188, 235-247.
14. Eimon, P.M., and Harland, R.M. (2002). Effects of heterodimerization and proteolytic processing on Derriere and Nodal activity: implications for mesoderm induction in Xenopus. Development 129, 3089-3103.
15. Entchev, E.V., Schwabedissen, A., and Gonzalez-Gaitan, M. (2000). Gradient formation of the TGF-beta homolog Dpp. Cell 103, 981-991.
16. Fujise, M., Takeo, S., Kamimura, K., Matsuo, T., Aigaki, T., Izumi, S., and Nakato, H. (2003). Dally regulates Dpp morphogen gradient formation in the Drosophila wing. Development 130, 1515-1522.
17. Gong, Y., et al. (1999). Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat. Genet. 21, 302-304.
18. Gonzalez-Gaitan, M. (2003). Signal dispersal and transduction through the endocytic pathway. Nat. Rev. Mol. Cell. Biol. 4, 213-224.
19. Hashimoto, O., Nakamura, T., Shoji, H., Shimasaki, S., Hayashi, Y., and Sugino, H. (1997). A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J. Biol. Chem. 272, 13835-13842.
20. Henrich, S., Cameron, A., Bourenkov, G.P., Kiefersauer, R., Huber, R., Lindberg, I., Bode, W., and Than, M.E. (2003). The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat. Struct. Biol. 10, 520-526.
21. Hicke, L., and Dunn, R. (2003). Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell. Dev. Biol. 39, 141-172.
22. Hogan, B.L. (1996). Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
23. Horton, R.M., Cai, Z., Ho, Z.N., and Pease, L.R. (1990). Gene splicing by overlap extension: tailor made genes using the polymerase chain reaction. Biotechniques 8, 528-536.
24. Israel, D.I., Nove, J., Kerns, K.M., Moutsatsos, I.K., and Kaufman, R.J. (1992). Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors 7, 139-150.
25. Jean, F., Stella, K., Thomas, L, Liu, G., Xiang, Y., Reason, A.J., and Thomas, G. (1998). alphal-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. USA 95, 7293-7298.
26. Jortikka, L., Laitinen, M., Lindholm, T.S., and Marttinen, A. (1997). Internalization and intracellular processing of bone morphogenetic protein (BMP) in rat skeletal muscle myoblasts (L6). Cell Signal. 9, 47-51.
27. Kaplan, P.S., and Shore, E.M. (1998). Encrypted morphogens of skeletogenesis: biological errors and pharmacologic potentials. Biochem. Pharmacol. 55, 373-382.
28. Kavsak, P., Rasmussen, R.K., Causing, C.G., Bonni, S., Zhu, H., Thomsen, G.H., and Wrana, J.L. (2000). Smad7 binds to Smur2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365-1375.
29. Keleman, K., Rajagopalan, S., Cleppien, D., Teis, D., Paiha, K., Huber, L.A., Technau, G.M., and Dickson, B.J. (2002). Comm sorts robo to control axon guidance at the Drosophila midline. Cell 330, 415-427.
30. Khokha, M.K., Hsu, D., Brunet, L.J., Dionne, M.S., and Harland, R.M. (2003). Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat. Genet. 34, 303-307.
31. Krysan, D.J., Rockwell, N.C., and Fuller, R.S. (1999). Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides. J. Biol. Chem. 274, 23229-23234.
32. Lander, A.D., Nie, Q., and Wan, F.Y. (2002). Do morphogen gradients arise by diffusion? Dev. Cell 2, 785-796.
33. Lawson, K.A., Dunn, N.R., Roelen, B.A., Zeinstra, L.M., Davis, A.M., Wright, C.V., Korving, J.P., and Hogan, B.L. (1999). Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 33, 424-436.
34. Longva, K.E., Blystad, F.D., Stang, E., Larsen, A.M., Johannessen, L.E., and Madshus, I.H. (2002). Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 356, 843-854.
35. McMahon, J.A., Takada, S., Zimmerman, L.B., Fan, C.M., Harland, R.M., and McMahon, A.P. (1998). Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 32, 1438-1452.
36. Melman, L., Geuze, H.J., Li, Y., McCormick, L.M., van Kerkhof, P., Strous, G.J., Schwartz, A.L., and Bu, G. (2002). Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway. Mol. Biol. Cell 13, 3325-3335.
37. Miyazaki, Y., Oshima, K., Fogo, A., Hogan, B.L., and Ichikawa, I. (2000). Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Investig. 205, 863-873.
38. Moon, R.T., and Christian, J.L. (1989). Microinjection and expression of synthetic mRNAs in Xenopus embryos. Technique 1, 76-89.
39. Murakami, G., Watabe, T., Takaoka, K., Miyazono, K., and Imamura, T. (2003). Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol. Biol. Cell 24, 2809-2817.
40. Nakagawa, T., Murakami, K., and Nakayama, K. (1993). Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease. FEBS Lett. 327, 165-171.
41. Nakayama, T., Cui, Y., and Christian, J.L. (2000). Regulation of BMP/Dpp signaling during embryonic development. Cell. Mol. Life Sci. 57, 943-956.
42. Neumann, C., and Cohen, S. (1997). Morphogens and pattern formation. Bioessays 29, 721-729.
43. Ohkawara, B., Iemura, S., ten Dijke, P., and Ueno, N. (2002). Action range of BMP is denned by its N-terminal basic amino acid core. Curr. Biol. 22, 205-209.
44. Podos, S.D., Hanson, K.K., Wang, Y.C., and Ferguson, E.L. (2001). The DSmurf ubiquitin-protein ligase restricts BMP signaling spatially and temporally during Drosophila embryogenesis. Dev. Cell 1, 567-578.
45. Rocca, A., Lamaze, C., Subtil, A., and Dautry-Varsat, A. (2001). Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol. Biol. Cell 12, 1293-1301.
46. Rockwell, N.C., Krysan, D.J., Komiyama, T., and Fuller, R.S. (2002). Precursor processing by kex2/furin proteases. Chem. Rev. 102, 4525-4548.
47. Seidah, N.G., Chretien, M., and Day, R. (1994). The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 76, 197-209.
48. Selleck, S.B. (2001). Genetic dissection of proteoglycan function in Drosophila and C. elegans. Semin. Cell Dev. Biol. 22, 127-134.
49. Seto, E.S., Bellen, H.J., and Lloyd, T.E. (2002). When cell biology meets development: endocytic regulation of signaling pathways. Genes Dev. 26, 1314-1336.
50. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
51. Siezen, R.J., Creemers, J.W., and Van de Ven, W.J. (1994). Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. Eur. J. Biochem. 222, 255-266.
52. Soetens, O., De Craene, J.O., and Andre, B. (2001). Ubiquitin is required for sorting to the vacuole of the yeast general amino acid permease, Gap1. J. Biol. Chem. 276, 43949-43957.
53. Sorkin, A., and Waters, C.M. (1993). Endocytosis of growth factor receptors. Bioessays 15, 375-382.
54. Tabata, T., and Takei, Y. (2004). Morphogens, their identification and regulation. Development 131, 703-712.
55. Takada, T., Katagiri, T., Ifuku, M., Morimura, N., Kobayashi, M., Hasegawa, K., Ogamo, A., and Kamijo, R. (2003). Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278, 43229-43235.
56. Thomas, G. (2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell. Biol. 3, 753-766.
57. van Kerkhof, P., Alves dos Santos, C.M., Sachse, M., Klumperman, J., Bu, G., and Strous, G.J. (2001). Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol. Biol. Cell 12, 2556-2566.
58. Winnier, G., Blessing, M., Labosky, P.A., and Hogan, B.L. (1995). Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9, 2105-2116.
59. Xiang, Y., Molloy, S.S., Thomas, L., and Thomas, G. (2000). The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments. Mol. Biol. Cell 11, 1257-1273.
60. Xiong, X., Bragin, A., Widdicombe, J.H., Cohn, J., and Skach, W.R. (1997). Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J. Clin. Investig. 100, 1079-1088.
61. Zhou, A., Webb, G., Zhu, X., and Steiner, D.F. (1999). Proteolytic processing in the secretory pathway. J. Biol. Chem. 274, 20745-20748.